Clinical Trials Logo

Laparoscopic Gastric Bypass clinical trials

View clinical trials related to Laparoscopic Gastric Bypass.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04595396 Completed - Obesity Clinical Trials

Laparoscopic Gastric Bypass as Metabolic Surgery in Obesity Class 1

Start date: September 1, 2012
Phase:
Study type: Observational

Prospective study including Mexican patients diagnosed with type 2 diabetes and class 1 obesity, undergoing laparoscopic gastric bypass. The objective was to determine short, mid-and long-term outcomes (weight loss, metabolic, morbidity and diabetes remission). A subanalysis was included, based on preoperative usage of one (Group A) or more antidiabetics ± insulin (Group B).

NCT ID: NCT03001843 Completed - Obesity Clinical Trials

Ketamine vs Hydromorphone

Start date: February 22, 2017
Phase: Phase 4
Study type: Interventional

This study will help to determine if investigators can minimize narcotic use in laparoscopic gastric bypass patients while maintaining adequate pain control. This will allow investigators to minimize the negative side effects of narcotics which is a goal in this population.

NCT ID: NCT00971750 Completed - Ultrasonography Clinical Trials

Laparoscopic Versus Transabdominal Ultrasound in Morbidly Obese Patients

Start date: October 2003
Phase: N/A
Study type: Observational

The objective of this study is to prospectively compare laparoscopic ultrasound to transabdominal ultrasound for the detection of gallbladder pathology in obese patients presenting for laparoscopic gastric bypass. We hypothesize that laparoscopic ultrasound will be more sensitive and specific for cholelithiasis than transabdominal ultrasound in morbidly obese patients.